Nordion Inc. Company Profile
Nordion Inc. (TSX: NDN) (NYSE: NDZ) is a global health science company that provides market-leading products used for the prevention, diagnosis and treatment of disease. We are a leading provider of medical isotopes, targeted therapies and sterilization technologies that benefit the lives of millions of people in more than 60 countries around the world. Our products are used daily by pharmaceutical and biotechnology companies, medical-device manufacturers, hospitals, clinics and research laboratories. Nordion has more than 500 highly skilled employees in three locations. Find out more at www.nordion.com and follow us at http://twitter.com/NordionInc
News Articles
BRIEF-U.S. shares of Nordion Inc drop in premarket
NEW YORK, Sept 10 (Reuters) - Nordion: * U.S. shares of Nordion Inc drop 30 percent in premarket
UPDATE 3-Medical isotope maker Nordion explores alternatives
* Nordion suspended dividend in Sept after arbitration defeat
Nordion posts 3rd-quarter profit
Sept 5 (Reuters) - Canadian medical isotope supplier Nordion Inc posted a quarterly profit, helped by growth in its Targeted Therapies segment.
Nordion's Future Does Not Look Bright
By A John Hodge:Nordion Inc. (NDZ) is a global life sciences company that has continued to innovate annually even as global supply of medical isotopes continued to challenge the company. However, Nord...
Nordion terminates Russian supply deal, begins new talks
* Nordion lost bid to have aging supply facility replaced
Nordion, Navidea Biopharmaceuticals ink contract manufacturing agreement
Nordion, a provider of products and services to the global health science market, has signed a contract manufacturing agreement with Navidea Biopharmaceuticals, a biopharmaceutical company focused on...
Nordion to Release Third Quarter 2012 Financial Results
Nordion Inc. (TSX: NDN) (NYSE: NDZ), a leading provider of products and services to the global health science market, today announced that the Company will report its third quarte...
Nordion unterzeichnet Vertrag über Verkauf seines Geschäftsbereichs Targeted Therapies an BTG plc
Nordion Inc. (TSX: NDN) (NYSE: NDZ), ein führender Anbieter von Produkten und Dienstleistungen zur Prävention, Diagnose und Behandlung von Krankheiten, gab heute den Abschluss eines Vertrags über ....
Drugs and Medications
None
PubMed Articles
Nordion retreats from defamation lawsuit.
Acyclic Chelate with Ideal Properties for (68)Ga PET Imaging Agent Elaboration.
We have investigated novel bifunctional chelate alternatives to the aminocarboxylate macrocycles NOTA (N(3)O(3)) or DOTA (N(4)O(4)) for application of radioisotopes of Ga to diagnostic nuclear medicin...
(68)Ga Small Peptide Imaging: Comparison of NOTA and PCTA.
In this study, a bifunctional version of the chelate PCTA was compared to the analogous NOTA derivative for peptide conjugation, (68)Ga radiolabeling, and small peptide imaging. Both p-SCN-Bn-PCTA and...
Clinical Trials
HDE Use Protocol of TheraSphere for Treatment of Unresectable HCC
MDS Nordion's TheraSphere, Yttrium-90 glass microspheres has been approved as a Humanitarian device authorized by federal(USA)law for use in radiation treatment or as a neoadjuvant to surg...
Companies
Nordion Inc. (TSX: NDN) (NYSE: NDZ) is a global health science company that provides market-leading products used for the prevention, diagnosis and treatment of disease. We are a...
We are one of the world’s foremost, global health and life sciences companies exporting medical isotopes, radiotherapeutics and related technologies to more than 60 countries around the world....
More Information about "Nordion Inc." on BioPortfolio
We have published hundreds of Nordion Inc. news stories on BioPortfolio along with dozens of Nordion Inc. Clinical Trials and PubMed Articles about Nordion Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Nordion Inc. Companies in our database. You can also find out about relevant Nordion Inc. Drugs and Medications on this site too.
